Combined epigenetic therapy and immune checkpoint blockade drive reshaping of the tumor microenvironment of platinum resistant ovarian cancer

被引：0
|
作者：
Landon, Blair V.
Kaleka, Guneet
Balan, Archana
Boland, Julia L.
Cherry, Christopher
Pereira, Gavin
Zahnow, Cynthia
Winterhoff, Boris
Baylin, Stephen
Velculescu, Victor E.
Konecny, Gottfried E.
Glaspy, John A.
Anagnostou, Valsamo
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7551
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Epigenetic Modulation of the Tumor Immune Microenvironment to Potentiate Immune Checkpoint Blockade Therapy
    Menzel, Johannes
    Black, Joshua C.
    [J]. CANCER DISCOVERY, 2020, 10 (02) : 179 - 181
  • [2] Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy
    Yunzhu Lin
    Xiang Wang
    Shi He
    Zhongxin Duan
    Yunchu Zhang
    Xiaodong Sun
    Yuzhu Hu
    Yuanyuan Zhang
    Zhiyong Qian
    Xiang Gao
    Zhirong Zhang
    [J]. Acta Pharmaceutica Sinica B, 2024, 14 (02) : 854 - 868
  • [3] Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy
    Lin, Yunzhu
    Wang, Xiang
    He, Shi
    Duan, Zhongxin
    Zhang, Yunchu
    Sun, Xiaodong
    Hu, Yuzhu
    Zhang, Yuanyuan
    Qian, Zhiyong
    Gao, Xiang
    Zhang, Zhirong
    [J]. ACTA PHARMACEUTICA SINICA B, 2024, 14 (02) : 854 - 868
  • [4] Epigenetic treatment of ovarian cancer cells increases immune cell recruitment to the tumor microenvironment: implications for response to immune checkpoint therapy
    Stone, Meredith L.
    Chiappinelli, Katherine B.
    Li, Huili
    Murphy, Lauren
    Topper, Michael
    Baylin, Stephen
    Zahnow, Cynthia
    [J]. CANCER RESEARCH, 2016, 76
  • [5] Combination immune checkpoint blockade and MEK inhibition in a platinum-resistant ovarian cancer model
    Hartnett, E. G.
    Edwards, R. P.
    Vlad, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 53 - 54
  • [6] The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
    Russell, Bonnie L.
    Sooklal, Selisha A.
    Malindisa, Sibusiso T.
    Daka, Lembelani Jonathan
    Ntwasa, Monde
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance
    Li, Yaqi
    Liu, Jing
    Gao, Long
    Liu, Yuan
    Meng, Fang
    Li, Xiaoan
    Qin, F. Xiao-Feng
    [J]. IMMUNOLOGY LETTERS, 2020, 220 : 88 - 96
  • [8] Immune checkpoint blockade in ovarian cancer
    Weiss, Lukas
    Huemer, Florian
    Mlineritsch, Brigitte
    Greil, Richard
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2016, 9 (02) : 82 - 84
  • [9] Immune checkpoint blockade for ovarian cancer
    Hamanishi, Junzo
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S259 - S259
  • [10] Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy
    Lu, Chia-Sing
    Lin, Ching-Wen
    Chang, Ya-Hsuan
    Chen, Hsuan-Yu
    Chung, Wei-Chia
    Lai, Wei-Yun
    Ho, Chao-Chi
    Wang, Tong-Hong
    Chen, Chi-Yuan
    Yeh, Chen-Lin
    Wu, Sean
    Wang, Shu-Ping
    Yang, Pan-Chyr
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
12345